Spectrum Pharma Inc (SPPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,697 | -17,634 | -13,799 | -11,446 | -6,306 |
| Depreciation Amortization | 88 | 917 | 1,121 | 798 | 437 |
| Other Working Capital | 280 | -1,941 | -2,768 | -704 | -709 |
| Other Operating Activity | -15 | 4,161 | 544 | 153 | 0 |
| Operating Cash Flow | $-1,344 | $-14,497 | $-14,903 | $-11,199 | $-6,578 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 6,209 | 6,016 | 5,990 | 6,090 |
| PPE Investments | 29 | 63 | 412 | -56 | -46 |
| Other Investing Activity | 0 | 0 | 21 | 20 | -3 |
| Investing Cash Flow | $29 | $6,272 | $6,448 | $5,954 | $6,042 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -87 | -653 | -564 | -492 | -407 |
| Common Stock Issued | 467 | 9,921 | 8,454 | 7,438 | 5,827 |
| Common Stock Repurchased | -1 | -143 | -143 | N/A | N/A |
| Other Financing Activity | 0 | -136 | 0 | 0 | 0 |
| Financing Cash Flow | $379 | $8,989 | $7,747 | $6,946 | $5,419 |
| Beginning Cash Position | 1,512 | 748 | 749 | 749 | 749 |
| End Cash Position | 576 | 1,512 | 41 | 2,451 | 5,632 |
| Net Cash Flow | $-936 | $764 | $-708 | $1,702 | $4,883 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,344 | -14,497 | -14,903 | -11,199 | -6,578 |
| Capital Expenditure | N/A | -59 | -59 | -56 | -46 |
| Free Cash Flow | -1,344 | -14,556 | -14,962 | -11,255 | -6,624 |